Why co-promotion with Israel company??? Three-year co-promotion agreement, where will the RedHill late stage pipeline drugs be in three years?? Why fill a NR with the current drugs in late stage that RedHill has in their pipeline??
RedHill plans to commercialize its leading drug candidates in the U.S., either through its own efforts or in conjunction with partners. Outside of the U.S. RedHill seeks commercialization partners for its products.
RedHill seeks to collaborate with pharmaceutical companies with a proven R&D track record and strong commercial capabilities.
RedHill also seeks to in-license or acquire FDA approved products, marketed in the U.S., in the therapeutic areas of GI, inflammation and oncology.
If you are interested in exploring partnering, licensing and business development opportunities with RedHill.
RedHill Biopharma Ltd.
21 Ha’arba’a St., Tel-Aviv 6473921, Israel
Mr. Oberman joined Teva in 2000 and served as President of Teva EMIA (
Eastern Europe,
Middle East,
Israel and
Africa), where he led a diverse group of countries in achieving consistent growth.
Mr. Oberman also served as the Chief Operating Officer of Teva International, and President and CEO of
Teva Canada, formerly known as Novopharm Limited.
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company headquartered in Petah Tikva, Israel.
JMO